Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Crop Life Science's other long-term liabilities for the quarter that ended in Mar. 2026 was ₹17 Mil.
Crop Life Science's quarterly other long-term liabilities
increased
from Mar. 2025 (₹9 Mil) to Sep. 2025 (₹19 Mil) but then
declined
from Sep. 2025 (₹19 Mil) to Mar. 2026 (₹17 Mil).
Crop Life Science's annual other long-term liabilities
declined
from Mar. 2024 (₹13 Mil) to Mar. 2025 (₹9 Mil) but then
increased
from Mar. 2025 (₹9 Mil) to Mar. 2026 (₹17 Mil).
Crop Life Science Other Long-Term Liabilities Related Terms
Crop Life Science Other Long-Term Liabilities Historical Data
* Premium members only.
The historical data trend for Crop Life Science's Other Long-Term Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science Other Long-Term Liabilities Chart
Crop Life Science Other Long-Term Liabilities Calculation
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
What does a Other Long-Term Liabilities of ₹17 Mil mean?
Crop Life Science (NSE:CLSL) has a Other Long-Term Liabilities of ₹17 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Crop Life Science and its competitors.
Is Crop Life Science's Other Long-Term Liabilities too high?
Crop Life Science's current Other Long-Term Liabilities is ₹17 Mil. Overall, Crop Life Science has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Other Long-Term Liabilities compare to CTVA and CF?
Crop Life Science's Other Long-Term Liabilities of ₹17 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for an Agriculture company?
A good Other Long-Term Liabilities depends on the Agriculture industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Crop Life Science and its competitors. Crop Life Science's current Other Long-Term Liabilities is ₹17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹56.19, compared to a current price of ₹80.00 — trading 42.4% above its estimated fair value. The current Other Long-Term Liabilities is ₹17 Mil. Crop Life Science's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Other Long-Term Liabilities is ₹17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued.
The current stock price of ₹80.00 is trading 42.4% above its estimated GF Value™ of ₹56.19.
GuruFocus considers Crop Life Science to be Significantly Overvalued.
Key valuation signals for NSE:CLSL:
Other Long-Term Liabilities: ₹17 Mil
GF Value™: ₹56.19 vs. price of ₹80.00 (42.4% above fair value)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
75GF Score
Get the complete analysis for NSE:CLSL
Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
